FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthias Cavassini

Research Profile

Disorders

Geographic Areas

Switzerland

Chemicals & Drugs

Concepts & Ideas

Living Beings

Procedures

Activities & Behaviors

Medication Adherence

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Aurélie Gertsch; Isabella Locatelli; Odile Michel; Martin Rickenbach; Olivier Bugnon; Matthias Cavassini; Marie-Paule Schneider
Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study.
Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthias Cavassini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Manel Aouri; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Bernard Hirschel; Andri Rauch; Amalio Telenti; Laurent A Decosterd
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Journal of mass spectrometry : JMS 2013;48(5):616-25.
2013: Aurélie Gertsch; Isabella Locatelli; Odile Michel; Martin Rickenbach; Olivier Bugnon; Matthias Cavassini; Marie-Paule Schneider
Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study.
AIDS patient care and STDs 2013;27(4):208-10.
2013: Rainer Weber; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; M Flepp; Hansjakob Furrer; J Kowalska; bruno ledergerber; Martin Rickenbach; M Ruppik; Patrick Schmid; A Spoerri
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.
HIV medicine 2013;14(4):195-207.
2013: Lukas Fenner; Reno Frei; Hansjakob Furrer; Sebastien Gagneux; Thomas Gsponer; Peter Helbling; Matthias Hoffmann; Jean-Paul Janssens; Hans L Rieder; Jacques Schrenzel; David Stucki; Marcel Zwahlen; Marie Ballif; Manuel Battegay; Enos Bernasconi; Thomas Bodmer; Sonia Borrell; Erik C Böttger; Alexandra Calmy; Matthias Cavassini; Marisa Dolina; Matthias Egger; Jan Fehr
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis.
PLoS genetics 2013;9(3):e1003318.
2013: Samanta Simioni; Jean-Marie Annoni; Alexandra Calmy; Matthias Cavassini; Aurélie Fayet-Mello; Ezio Giacobini; Bernard Hirschel; Katia Iglesias; Samantha Jilek; Mélanie Métral; Hubertus Müller; Aline Rimbault Abraham; Renaud A Du Pasquier
Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.
Neurology 2013;80(6):553-60.
2013: Noémie Boillat-Blanco; Maddalena Adami; Samira Daou; Katharine E A Darling; Luigia Elzi; Jan Fehr; Regina Osih; Carol Strahm; Patrick Taffe; Gilles Wandeler; Matthias Cavassini
Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study.
Journal of acquired immune deficiency syndromes (1999) 2013;62(2):180-9.
2013: Renaud A Du Pasquier; Christoph A Fux; Huldrych F Günthard; Christine Gutmann; Samantha Jilek; Malela Kalubi; Pietro L Vernazza; Sabine Yerly; Matthias Cavassini; Alexia Cusini
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy.
AIDS (London, England) 2013;27(2):203-10.
2013: Annatina Schnegg; Jacques Izopet; Alain Kenfak-Foguena; Darius Moradpour; Florence Abravanel; Cyril André; Philippe Bürgisser; Giorgia Canellini; Matthias Cavassini; Katharine E A Darling
An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population.
PloS one 2013;8(5):e62980.
2013: Qing Wang; Rainer Weber; Jim Young; Enos Bernasconi; Heiner C Bucher; Matthias Cavassini; Hansjakob Furrer; Christoph Fux; Bernard Hirschel; Marcel Stoeckle; Pietro Vernazza
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study.
Antiviral therapy 2013;18(3):337-44.
2013: Matthias Cavassini; Renaud A Du Pasquier
A light in the cognitive fog?
Antiviral therapy 2013;18(2):149-51.
2013: Rubin Lubomirov; Raquel Martinez; Catia Marzolini; Margalida Rotger; Amalio Telenti; Mona Arab-Alameddine; Enos Bernasconi; Thierry Buclin; Alexandra Calmy; Matthias Cavassini; Chantal Csajka; Laurent A Decosterd; Julia di Iulio; Aurélie Fayet-Mello; Hansjakob Furrer; Monia Guidi; Huldrych F Günthard
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Pharmacogenetics and genomics 2013;23(1):9-18.
2013: Alexia Cusini; Laurent A Decosterd; Christoph A Fux; Roman Gaudenz; Huldyrich F Günthard; Chistine Gutmann; Bernhard Hirschel; Thomas Klimkait; bruno ledergerber; Milos Opravil; Janine Rohrbach; Pietro L Vernazza; Nicolas Widmer; Sabine Yerly; Franziska Zenger; Matthias Cavassini
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.
Journal of acquired immune deficiency syndromes (1999) 2013;62(1):28-35.
2013: Aurélie Fayet-Mello; Claudia Grawe; Erika Gremlich; Nicole Guignard; Begoña Martinez de Tejada; Karoline Aebi Popp; Flavia Schmid; Amalio Telenti; Jérôme Biollaz; Thierry Buclin; Matthias Cavassini; Sandra Cruchon; Laurent A Decosterd; Chin B Eap
Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.
Antiviral therapy 2013;18(2):171-82.
2012: Stefano Giulieri; Matthias Cavassini; Katia Jaton
Mycobacterium chelonae illnesses associated with tattoo ink.
The New England journal of medicine 2012;367(24):2357; author reply 2357-8.
2012: Alexandre Harari; Joep Lange; Christiane Moog; Giuseppe Pantaleo; Virginie Rozot; Gonzalo Tapia; Selena Vigano; Séverine Burnet; Erika Castro; Matthias Cavassini; Dominique Costagliola; Felicitas Bellutti Enders; Daniel Garin; Brigitte Autran; Pierre-Alexandre Bart
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
European journal of immunology 2012;42(11):3038-48.
2012: Julie Delaloye; Marlies Knaup Reymond; Thierry Roger; Fred C G J Sweep; Thierry Calandra; Katharine E A Darling; Irma J A De Bruin; Matthias Cavassini
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection.
Cytokine 2012;60(2):338-40.
2012: Guillaume Gras; Magalie Loilier; Frédéric Lucht; Louis Bernard; Matthias Cavassini; Marie-Paule Schneider; Renaud Verdon; Jean-Jacques Parienti
Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: the RALTECAPS cohort study.
Journal of acquired immune deficiency syndromes (1999) 2012;61(3):265-9.
2012: Katharine E A Darling; Esther-Amélie Diserens; Eric Masserey; Chantal N'garambe; Anne Ansermet-Pagot; Matthias Cavassini; Patrick Bodenmann
A cross-sectional survey of attitudes to HIV risk and rapid HIV testing among clients of sex workers in Switzerland.
Sexually transmitted infections 2012;88(6):462-4.
2012: Luigia Elzi; Stefan Erb; Hansjakob Furrer; Bernard Hirschel; bruno ledergerber; Pietro Vernazza; Rainer Weber; Manuel Battegay; Enos Bernasconi; Matthias Cavassini
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes.
Archives of internal medicine 2012;172(17):1313-21.
2012: Chloe Kaech; Isabelle Pache; Philippe Bürgisser; Katharine E A Darling; Luigia Elzi; Matthias Cavassini
Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
The Journal of infection 2012;65(2):157-64.
2012: Isabelle Krummenacher; Olivier Bugnon; Matthias Cavassini; Marie P Schneider
Characteristics of HIV patients referred to a medication adherence program in Switzerland.
International journal of clinical pharmacy 2012;34(3):426-31.
2012: Mona Arab-Alameddine; Marta Boffito; Thierry Buclin; Matthias Cavassini; Chantal Csajka; Laurent A Decosterd; Julia di Iulio; Aurélie Fayet-Mello; Huldrych Günthard; Rubin Lubomirov; Michael Neely; Andrew Owen; Katharina Rentsch; Margalida Rotger; Amalio Telenti; Manel Aouri
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.
Antimicrobial agents and chemotherapy 2012;56(6):2959-66.
2012: Heiner C Bucher; Matthias Cavassini; Hansjakob Furrer; Tracy R Glass; Bernard Hirschel; Lorenzo Magenta; Werner Richter; Pietro Vernazza; Qing Wang; Rainer Weber; Manuel Battegay; Enos Bernasconi
Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2012;60(2):135-42.
2012: Elisa De Crignis; Antonio Fabio Di Narzo; Brian Thomas Foley; Silvia Guglietta; Matteo Negroni; Giuseppe Pantaleo; Vreneli Waelti Da Costa; Pierre-Alexandre Bart; Matthias Cavassini; C Graziosi
Nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (RNY)(n) in gp120 of HIV Type1.
AIDS research and human retroviruses 2012;28(5):493-504.
2012: Jim Young; Manuel Battegay; Enos Bernasconi; Heiner C Bucher; Alexandra Calmy; Matthias Cavassini; Hansjakob Furrer; Christoph A Fux; Juliane Schäfer; Pietro Vernazza; Rainer Weber
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.
AIDS (London, England) 2012;26(5):567-75.
2012: Mai-Anh Ducommun; Simone Eperon; Matthias Cavassini; Mona B Khonkarly; Yan Guex-Crosier
Long-term close follow-up of chorioretinal lesions in presumed ocular tuberculosis.
European journal of ophthalmology 2012;22(2):195-202.
2012: C Thierfelder; Rainer Weber; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; C Gutmann; bruno ledergerber
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
HIV medicine 2012;13(2):118-26.
2012: Olivia Keiser; bruno ledergerber; Dunja Nicca; Andri Rauch; Ben Spycher; Alexandra Calmy; Matthias Cavassini; Matthias Egger; Tracy R Glass
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis.
AIDS and behavior 2012;16(2):245-55.
2012: Gary M Clifford; M Egger; S Ess; J Fehr; Silvia Franceschi; Gernot Jundt; Olivia Keiser; D Korol; Fabio Levi; M Lise; P Schmid; F Schöni-Affolter; G Wandeler; M Battegay; E Bernasconi; Christine Bouchardy; A Calmy; Matthias Cavassini
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
British journal of cancer 2012;106(3):447-52.
2012: Alexandra U Scherrer; Pietro L Vernazza; Sabine Yerly; Vincent Aubert; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Huldrych F Günthard; Thomas Klimkait; bruno ledergerber
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
PloS one 2012;7(11):e50307.
2012: Claire-Anne Siegrist; Paola M Soccal; Christian van Delden; Sabine Yerly; Michael Bel; Alexandra Calmy; Matthias Cavassini; Olivier Clerc; Christophe Combescure; Cécile Delhumeau; Karine Hadaya; Bernard Hirschel; Laurent Kaiser; Sara Meier
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.
PloS one 2012;7(7):e40428.
2012: Katharine E A Darling; Renaud A Du Pasquier; Olivier W Hugli; Rachel Mamin; Sebastien Martenet; Solange Peters; Alexandre Berney; Patrick Bodenmann; Cristina Cellerai; Matthias Cavassini
HIV testing practices by clinical service before and after revised testing guidelines in a Swiss University Hospital.
PloS one 2012;7(6):e39299.
2012: Alexandra U Scherrer; Pietro L Vernazza; Viktor von Wyl; Sabine Yerly; Enos Bernasconi; Jürg Böni; Alexandra Calmy; Matthias Cavassini; Cristina Cellerai; Luigia Elzi; Hansjakob Furrer; Huldrych Günthard; Thomas Klimkait; bruno ledergerber
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
PloS one 2012;7(6):e37983.
2012: Lukas Fenner; Sebastien Gagneux; Peter Helbling; Matthias Hoffmann; Jean-Paul Janssens; Jacques Schrenzel; Enos Bernasconi; Thomas Bodmer; Erik C Böttger; Matthias Cavassini; Matthias Egger; Jan Fehr
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes.
PloS one 2012;7(3):e34186.
2012: Cathy Voide; Katharine E A Darling; Matthias Cavassini; Véronique Erard; Alain Kenfak-Foguena; Catherine Lazor-Blanchet
Underreporting of needlestick and sharps injuries among healthcare workers in a Swiss University Hospital.
Swiss medical weekly 2012;142():0.
2012: Erika Castro; Matthias Cavassini; Patricia Recordon-Pinson; Hervé Fleury
Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infection.
Antiviral therapy 2012;17(3):593-4.
2012: Viktor von Wyl; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Jürg Böni; Matthias Cavassini; Cristina Cellerai; Hansjakob Furrer; Huldrych Günthard; Bernard Hirschel; Thomas Klimkait; bruno ledergerber; Cyril Shah; Pietro L Vernazza
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(1):131-40.
2012: Cornelia Staehelin; Rainer Weber; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Olivia Keiser; Patrick Schmid
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2012;59(1):79-85.
2011: Viktor von Wyl; Rainer Weber; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Sebastian Bonhoeffer; Jürg Böni; Philippe Bürgisser; Matthias Cavassini; Huldrych Günthard; Bernard Hirschel; Thomas Klimkait; Roger D Kouyos; bruno ledergerber; Cyril Shah; Cornelia Staehelin; Pietro L Vernazza
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.
The Journal of infectious diseases 2011;204(7):1095-103.
2011: Catia Marzolini; Pietro Vernazza; Rainer Weber; David Back; Manuel Battegay; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Hansjakob Furrer; Saye Khoo
Ageing with HIV: medication use and risk for potential drug-drug interactions.
The Journal of antimicrobial chemotherapy 2011;66(9):2107-11.
2011: E Boffi El Amari; Hansjakob Furrer; Barbara Hasse; Hh Hirsch; Bernard Hirschel; L Kaiser; Pietro Vernazza; Sabine Yerly; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Christophe Combescure
Clinical relevance of cytomegalovirus viraemia(*,†).
HIV medicine 2011;12(7):394-402.
2011: Alain Nguyen; Andri Rauch; Patrick Schmid; Aurelie F Mello; Isabelle Mercier; Enos Bernasconi; Alexandra Calmy; Matthias Cavassini; Cecile Delhumeau; Luigia Elzi; Bernard Hirschel
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study).
AIDS (London, England) 2011;25(12):1481-7.
2011: Anne Pelet; Jacques Besson; Matthias Cavassini; Chin B Eap; Bernard Favrat; Martine Monnat
Usefulness of methadone plasma concentration measurement in patients receiving nevirapine or efavirenz.
The American journal of drug and alcohol abuse 2011;37(4):264-8.
2011: Aurélie Fayet Mello; Claudia Franc; Nicole Guignard; Amalio Telenti; Jérôme Biollaz; Thierry Buclin; Sara Colombo; Sandra Cruchon; Laurent A Decosterd; Matthias Cavassini
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.
The Journal of antimicrobial chemotherapy 2011;66(7):1573-81.
2011: E Gloor; G Meystre-Agustoni; Paul Vaucher; A Ansermet-Pagot; Patrick Bodenmann; S Durieux-Paillard; Matthias Cavassini
[Sex workers: limited access to healthcare].
Revue médicale suisse 2011;7(301):1429-33.
2011: Alexandra U Scherrer; Pietro L Vernazza; Viktor von Wyl; Sabine Yerly; Manuel Battegay; Enos Bernasconi; Jürg Böni; Philippe Bürgisser; Matthias Cavassini; Christian Garzoni; Huldrych F Günthard; Bernard Hirschel; Thomas Klimkait; bruno ledergerber
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2011;57(1):24-31.
2011: Isabelle Krummenacher; Matthias Cavassini; Olivier Bugnon; Marie P Schneider
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring.
AIDS care 2011;23(5):550-61.
2011: Jim Young; A U Scherrer; Milos Opravil; Sabine Yerly; Jürg Böni; Martin Rickenbach; Matthias Cavassini; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Manuel Battegay; Heiner C Bucher; C A Fux; H F Günthard
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.
HIV medicine 2011;12(5):299-307.
2011: bruno ledergerber; Matthias Cavassini; Manuel Battegay; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Rainer Weber
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
HIV medicine 2011;12(5):279-88.
2011: S Barelli; A Kenfak Foguena; D Periard; A Angelillo-Scherrer; Matthias Cavassini
[Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients].
Revue médicale suisse 2011;7(292):905-10.
2011: Alexandre Harari; Virginie Rozot; Felicitas Bellutti Enders; Matthieu Perreau; Jesica Mazza Stalder; Laurent P Nicod; Matthias Cavassini; Thierry Calandra; Catherine Lazor Blanchet; Katia Jaton; Mohamed Faouzi; Cheryl L Day; Willem A Hanekom; Pierre-Alexandre Bart; Giuseppe Pantaleo
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease.
Nature medicine 2011;17(3):372-6.
2011: Millán Ortiz; Estella S Poloni; Hansjakob Furrer; Helen Kovari; Raquel Martinez; Mireia Arnedo; Luigia Elzi; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; bruno ledergerber; Huldrych Günthard; Amalio Telenti; Philip E Tarr
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
The Journal of infectious diseases 2011;203(5):620-4.
2011: Stefano Giulieri; Benoit Morisod; Timothy Edney; Micaela Odman; Daniel Genné; Raffaele Malinverni; Catherine Hammann; Enrico Musumeci; Cathy Voide; Gilbert Greub; Eric Masserey; Jacques Bille; Matthias Cavassini; Katia Jaton
Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(4):488-91.
2011: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Philip Rieder; Beda Joos; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Andri Rauch; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; bruno ledergerber; Sebastian Bonhoeffer; Huldrych Günthard
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(4):532-9.
2011: Oriol Manuel; Manuel Pascual; Katja Hoschler; Stefano Giulieri; Deolinda Alves; Kim Ellefsen; Pierre-Alexandre Bart; Jean-Pierre Venetz; Thierry Calandra; Matthias Cavassini
Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(2):248-56.
2011: Rubin Lubomirov; Sara Colombo; Julia di Iulio; bruno ledergerber; Raquel Martinez; Matthias Cavassini; Bernard Hirschel; Enos Bernasconi; Luigia Elzi; Pietro Vernazza; Hansjakob Furrer; Huldrych Günthard; Amalio Telenti
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.
The Journal of infectious diseases 2011;203(2):246-57.
2011: Alain Nguyen; Alexandra Calmy; Cécile Delhumeau; Isabelle K Mercier; Matthias Cavassini; Aurélie Fayet-Mello; Luigia Elzi; Daniel Genné; Andri Rauch; Enos Bernasconi; Bernard Hirschel
A randomized crossover study to compare efavirenz and etravirine treatment.
AIDS (London, England) 2011;25(1):57-63.
2011: Luigia Elzi; Jan Fehr; Hansjakob Furrer; Bernard Hirschel; Matthias Hoffmann; Ingrid Steffen; Stefano Bassetti; Enos Bernasconi; Matthias Cavassini; Manuel Battegay
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection.
BMC infectious diseases 2011;11():319.
2011: Annatina Kaufmann; Alain Kenfak-Foguena; Darius Moradpour; Katharine E A Darling; Cyril André; Philippe Bürgisser; Giorgia Canellini; Matthias Cavassini
Hepatitis E virus seroprevalence among blood donors in southwest Switzerland.
PloS one 2011;6(6):e21150.
2011: Sara Gianella; Huldrych F Günthard; Bernard Hirschel; Beda Joos; Barbara Niederoest; Andri Rauch; Pietro Vernazza; Viktor von Wyl; Rainer Weber; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Marek Fischer
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.
Antiviral therapy 2011;16(4):535-45.
2011: Aurélie Fayet Mello; Thierry Buclin; Laurent A Decosterd; Cécile Delhumeau; Julia di Iulio; Alessandra Fleurent; Marie-Paule Schneider; Matthias Cavassini; Amalio Telenti; Bernard Hirschel; Alexandra Calmy
Successful efavirenz dose reduction guided by therapeutic drug monitoring.
Antiviral therapy 2011;16(2):189-97.
2011: Jan Fehr; Tracy R Glass; Séverine Louvel; François Hamy; Hans H Hirsch; Viktor von Wyl; Jürg Böni; Sabine Yerly; Philippe Bürgisser; Matthias Cavassini; Christoph A Fux; Bernard Hirschel; Pietro Vernazza; Gladys Martinetti; Enos Bernasconi; Huldrych Günthard; Manuel Battegay; Heiner C Bucher; Thomas Klimkait
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.
Journal of translational medicine 2011;9():14.
2010: Barbara Hasse; bruno ledergerber; Bernard Hirschel; Pietro Vernazza; Tracy R Glass; André Jeannin; John-Marc Evison; Luigia Elzi; Matthias Cavassini; Enos Bernasconi; Dunja Nicca; Rainer Weber
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(11):1314-22.
2010: Isabelle Krummenacher; Matthias Cavassini; Olivier Bugnon; Rebecca Spirig; Marie P Schneider
Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study.
Pharmacy world & science : PWS 2010;32(6):776-86.
2010: Regina B Osih; Patrick Taffé; Martin Rickenbach; Angèle Gayet-Ageron; Luigia Elzi; Christoph Fux; Milos Opravil; Enos Bernasconi; Patrick Schmid; Huldrych F Günthard; Matthias Cavassini
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.
AIDS research and human retroviruses 2010;26(11):1239-46.
2010: Margalida Rotger; Thomas Gsponer; Raquel Martinez; Patrick Taffé; Luigia Elzi; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Bernard Hirschel; Hansjakob Furrer; Rainer Weber; bruno ledergerber; Matthias Egger; Amalio Telenti; Philip E Tarr
Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(9):1090-8.
2010: Erika Castro; Mona Khonkarly; Donatella Ciuffreda; Philippe Bürgisser; Matthias Cavassini; Sabine Yerly; Giuseppe Pantaleo; Pierre-Alexandre Bart
HIV-1 drug resistance transmission networks in southwest Switzerland.
AIDS research and human retroviruses 2010;26(11):1233-8.
2010: F Tissot; V Erard; T Dang; Matthias Cavassini
Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.
HIV medicine 2010;11(9):584-92.
2010: Christine Gutmann; Alexia Cusini; Huldrych F Günthard; Christoph Fux; Bernard Hirschel; Laurent-Arthur Decosterd; Matthias Cavassini; Sabine Yerly; Pietro L Vernazza
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.
AIDS (London, England) 2010;24(15):2347-54.
2010: Frank A Post; Graeme J Moyle; Hans Jürgen Stellbrink; Pere Domingo; Daniel Podzamczer; Martin Fisher; Anthony G Norden; Matthias Cavassini; Armin Rieger; Marie-Aude Khuong-Josses; Teresa Branco; Helen C Pearce; Naomi Givens; Cindy Vavro; Michael L Lim
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
Journal of acquired immune deficiency syndromes (1999) 2010;55(1):49-57.
2010: Maria Christine Thurnheer; Rainer Weber; Laurence Toutous-Trellu; Matthias Cavassini; Luigia Elzi; Patrick Schmid; Enos Bernasconi; Anna B Christen; Marcel Zwahlen; Hansjakob Furrer
Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study.
AIDS (London, England) 2010;24(12):1907-16.
2010: Silvia Franceschi; M Lise; Gary M Clifford; Martin Rickenbach; Fabio Levi; M Maspoli; Christine Bouchardy; S Dehler; Gernot Jundt; S Ess; A Bordoni; I Konzelmann; H Frick; Luigino Dal Maso; L Elzi; Hansjakob Furrer; A Calmy; Matthias Cavassini; bruno ledergerber; Olivia Keiser
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
British journal of cancer 2010;103(3):416-22.
2010: Daniel Schroeder; Alain Kenfak Foguena; Alain Cometta; Gilbert Greub; Matthias Cavassini
A 48-year-old man with laryngeal mass and vocal cord palsy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1635, 1680-1.
2010: Tracy R Glass; Manuel Battegay; Matthias Cavassini; Sabina De Geest; Hansjakob Furrer; Pietro L Vernazza; Bernard Hirschel; Enos Bernasconi; Martin Rickenbach; Huldrych Günthard; Heiner C Bucher
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2010;54(2):197-203.
2010: Samanta Simioni; Matthias Cavassini; Jean-Marie Annoni; Aline Rimbault Abraham; Isabelle Bourquin; Véronique Schiffer; Alexandra Calmy; Jean-Philippe Chave; Ezio Giacobini; Bernard Hirschel; Renaud A Du Pasquier
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
AIDS (London, England) 2010;24(9):1243-50.
2010: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Hansjakob Furrer; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; bruno ledergerber; Sebastian Bonhoeffer; Huldrych Günthard
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
The Journal of infectious diseases 2010;201(10):1488-97.
2010: Rubin Lubomirov; Julia di Iulio; Aurélie Fayet; Sara Colombo; Raquel Martinez; Catia Marzolini; Hansjakob Furrer; Pietro Vernazza; Alexandra Calmy; Matthias Cavassini; bruno ledergerber; Katharina Rentsch; Patrick Descombes; Thierry Buclin; Laurent A Decosterd; Chantal Csajka; Amalio Telenti
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Pharmacogenetics and genomics 2010;20(4):217-30.
2010: Sabine Blum; Matthias Cavassini; Jean-François Lambert; Aurélie Fayet; Marc Schapira; Martine Jotterand
Treatment of 5q-syndrome with lenalidomide in an HIV-positive patient under cART.
Annals of hematology 2010;89(4):425-6.
2010: Luigia Elzi; Catia Marzolini; Hansjakob Furrer; bruno ledergerber; Matthias Cavassini; Bernard Hirschel; Pietro Vernazza; Enos Bernasconi; Rainer Weber; Manuel Battegay
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
Archives of internal medicine 2010;170(1):57-65.
2010: Catia Marzolini; Luigia Elzi; Sara Gibbons; Rainer Weber; Christoph Fux; Hansjakob Furrer; Jean-Philippe Chave; Matthias Cavassini; Enos Bernasconi; Alexandra Calmy; Pietro Vernazza; Saye Khoo; bruno ledergerber; David Back; Manuel Battegay
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Antiviral therapy 2010;15(3):413-23.
2010: Esther-Amélie Diserens; Patrick Bodenmann; Chantal N'Garambe; Anne Ansermet-Pagot; Marco Vannotti; Eric Masserey; Matthias Cavassini
Clients of sex workers in Switzerland: it makes sense to counsel and propose rapid test for HIV on the street, a preliminary report.
BMC infectious diseases 2010;10():74.
2009: Margalida Rotger; Cornelia Bayard; Patrick Taffé; Raquel Martinez; Matthias Cavassini; Enos Bernasconi; Manuel Battegay; Bernard Hirschel; Hansjakob Furrer; Andrea Witteck; Rainer Weber; bruno ledergerber; Amalio Telenti; Philip E Tarr
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Circulation. Cardiovascular genetics 2009;2(6):621-8.
2009: Thanh Dang; Katia Jaton-Ogay; Markus Flepp; Helen Kovari; John-Marc Evison; Jan Fehr; Patrick Schmid; Emmanuelle Boffi El Amari; Matthias Cavassini; Massimo Odorico; Philip E Tarr; Gilbert Greub
High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1532-5.
2009: Christophe Combescure; N Vallier; bruno ledergerber; Matthias Cavassini; Hansjakob Furrer; A Rauch; Manuel Battegay; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel
How reliable is an undetectable viral load?
HIV medicine 2009;10(8):470-6.
2009: Rainer Weber; M Huber; Martin Rickenbach; Hansjakob Furrer; Luigia Elzi; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; bruno ledergerber
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
HIV medicine 2009;10(7):407-16.
2009: Luigia Elzi; Gilbert Kaufmann; Rainer Weber; Christoph A Fux; Matthias Cavassini; Bernard Hirschel; Pietro Vernazza; Enos Bernasconi; Manuel Battegay
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individuals.
HIV clinical trials 2009;10(4):207-14.
2009: A Fayet; A Béguin; Boris Zanolari; S Cruchon; N Guignard; Amalio Telenti; Matthias Cavassini; Huldrych Günthard; Thierry Buclin; Jérôme Biollaz; Bertrand Rochat; Laurent A Decosterd
A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(11-12):1057-69.
2009: Viktor von Wyl; Sabine Yerly; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Hansjakob Furrer; Bernard Hirschel; Pietro L Vernazza; Patrick Francioli; Sebastian Bonhoeffer; bruno ledergerber; Huldrych Günthard
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):979-87.
2009: Olivia Veit; Matthias Niedrig; Caroline Chapuis-Taillard; Matthias Cavassini; Erik Mossdorf; Patrick Schmid; Hi-Gung BAe; Nadine Litzba; Thomas Staub; Christoph Hatz; Hansjakob Furrer
Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):659-66.
2009: Andreas J Flammer; N T T Vo; bruno ledergerber; Frank Hermann; A Gämperli; A Huttner; J Evison; Iris Baumgartner; Matthias Cavassini; Daniel Hayoz; Kurt Quitzau; Martin Hersberger; Isabella Sudano; Frank Ruschitzka; Thomas F Lüscher; Georg Noll; Rainer Weber
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial.
Heart (British Cardiac Society) 2009;95(5):385-90.
2009: Karin J Metzner; Stefano G Giulieri; Stefanie A Knoepfel; Pia Rauch; Philippe Burgisser; Sabine Yerly; Huldrych Günthard; Matthias Cavassini
Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(2):239-47.
2009: Marie Ballif; bruno ledergerber; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Bernard Hirschel; Hansjakob Furrer; Martin Rickenbach; Milos Opravil; Rainer Weber
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
PloS one 2009;4(12):e8275.
2009: Jim Young; Heiner C Bucher; Huldrych F Guenthard; Martin Rickenbach; Christoph A Fux; Bernard Hirschel; Matthias Cavassini; Pietro Vernazza; Enos Bernasconi; Manuel Battegay
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.
Antiviral therapy 2009;14(6):771-9.
2009: Anna Conen; Jan Fehr; Tracy R Glass; Hansjakob Furrer; Rainer Weber; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Heiner C Bucher; Manuel Battegay
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
Antiviral therapy 2009;14(3):349-57.
2009: Jean-Blaise Wasserfallen; Alexandre Hyjazi; Matthias Cavassini
Comparison of HIV-infected patients' characteristics, healthcare resources use and cost between native and migrant patients.
International journal of public health 2009;54(1):5-10.
2008: Olivier Pasche; Pierre-Yves Rodondi; Matthias Cavassini; Florian Barras; Jacques Cornuz
[Acute sinusitis].
Revue médicale suisse 2008;4(181):2560-2.
2008: Nina Khanna; Milos Opravil; Hansjakob Furrer; Matthias Cavassini; Pietro Vernazza; Enos Bernasconi; Rainer Weber; Bernard Hirschel; Manuel Battegay; Gilbert R Kaufmann
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1093-101.
2008: Donatella Ciuffreda; Denis Comte; Matthias Cavassini; Emiliano Giostra; Leo Bühler; Monika Perruchoud; Markus H Heim; Manuel Battegay; Daniel Genné; Beat Mulhaupt; Raffaele Malinverni; Carl Oneta; Enos Bernasconi; Martine Monnat; Andreas Cerny; Christian Chuard; Jan Borovicka; Gilles Mentha; Manuel Pascual; Jean-Jacques Gonvers; Giuseppe Pantaleo; Valérie Dutoit
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
European journal of immunology 2008;38(10):2665-77.
2008: Silvia Franceschi; L Dal Maso; Martin Rickenbach; Jerry Polesel; Bernard Hirschel; Matthias Cavassini; A Bordoni; L Elzi; S Ess; Gernot Jundt; N Mueller; Gary M Clifford
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
British journal of cancer 2008;99(5):800-4.
2008: Daniel Periard; Giuseppe Siniscalchi; Matthias Cavassini; Samuel Rotman; Erik Haesler
Severe atherosclerotic aortoiliac occlusive disease in a young HIV-infected patient.
The Lancet infectious diseases 2008;8(9):582.
2008: Aurélie Fayet; Alexandre Béguin; Begona Martinez de Tejada; Sara Colombo; Matthias Cavassini; Stefan Gerber; Chin B Eap; Amalio Telenti; Thierry Buclin; Jérôme Biollaz; Laurent A Decosterd
Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.
Therapeutic drug monitoring 2008;30(4):511-22.
2008: Dorothea M Wunder; C A Fux; Nick A Bersinger; Nicolas Mueller; Bernard Hirschel; Matthias Cavassini; Luigia Elzi; Patrick Schmid; Enos Bernasconi; B Mueller; Hansjakob Furrer
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study.
HIV medicine 2008;9(6):427-32.
2008: Marcel Wolbers; Heiner C Bucher; Hansjakob Furrer; Martin Rickenbach; Matthias Cavassini; Rainer Weber; Patrick Schmid; Enos Bernasconi; Bernard Hirschel; Manuel Battegay
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
HIV medicine 2008;9(6):397-405.
2008: Thi Tuyet Nhung Vo; bruno ledergerber; Olivia Keiser; Bernard Hirschel; Hansjakob Furrer; Manuel Battegay; Matthias Cavassini; Enos Bernasconi; Pietro Vernazza; Rainer Weber
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.
The Journal of infectious diseases 2008;197(12):1685-94.
2008: Emmanuelle Boffi El Amari; Laurence Toutous-Trellu; Angèle Gayet-Ageron; Michele Baumann; Gieri Cathomas; Ingrid Steffen; Peter Erb; Nicolas Mueller; Hansjakob Furrer; Matthias Cavassini; Pietro Vernazza; Hans Hirsch; Enos Bernasconi; Bernard Hirschel
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
AIDS (London, England) 2008;22(9):1019-28.
2008: Viktor von Wyl; Sabine Yerly; Jürg Böni; Philippe Bürgisser; Thomas Klimkait; Manuel Battegay; Enos Bernasconi; Matthias Cavassini; Hansjakob Furrer; Bernard Hirschel; Pietro L Vernazza; Martin Rickenbach; bruno ledergerber; Huldrych Günthard
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1299-309.
2008: Daniel Periard; Matthias Cavassini; Patrick Taffé; Melanie Chevalley; Laurence Senn; Caroline Chapuis-Taillard; Serge de Vallière; Daniel Hayoz; Philip E Tarr
High prevalence of peripheral arterial disease in HIV-infected persons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(5):761-7.
2008: Melanie Cuttelod; Andres Pascual; Audrey S Baur Chaubert; Alain Cometta; Regina Osih; Michel A Duchosal; Matthias Cavassini
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
AIDS (London, England) 2008;22(4):549-51.
2008: Christoph A Fux; Andri Rauch; Mathew Simcock; Heiner C Bucher; Bernard Hirschel; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Luigia Elzi; Hansjakob Furrer
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
Antiviral therapy 2008;13(8):1077-82.
2008: Andri Rauch; Silvana Gaudieri; John Evison; David Nolan; Matthias Cavassini; Rainer Weber; Ian James; Hansjakob Furrer
Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study.
Antiviral therapy 2008;13(3):455-60.
2007: Stefano Giulieri; Veronique Schiffer; Sabine Yerly; Philippe Burgisser; Bernard Hirschel; Matthias Cavassini
The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral load.
Archives of internal medicine 2007;167(22):2524-6.
2007: Marcel Wolbers; Milos Opravil; Viktor von Wyl; Bernard Hirschel; Hansjakob Furrer; Matthias Cavassini; Pietro Vernazza; Enos Bernasconi; Manuel Battegay; Sabine Yerly; Huldrych Günthard; Heiner C Bucher
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
AIDS (London, England) 2007;21(16):2201-7.
2007: bruno ledergerber; Hansjakob Furrer; Martin Rickenbach; Roger Lehmann; Luigia Elzi; Bernard Hirschel; Matthias Cavassini; Enos Bernasconi; Patrick Schmid; Matthias Egger; Rainer Weber
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(1):111-9.
2007: Tracy R Glass; Rainer Weber; Pietro L Vernazza; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Matthias Cavassini; Bernard Hirschel; Manuel Battegay; Heiner C Bucher
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
HIV clinical trials 2007;8(2):77-85.
2007: Christoph A Fux; Mathew Simcock; Marcel Wolbers; Heiner C Bucher; Bernard Hirschel; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Luigia Elzi; Hansjakob Furrer
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
Antiviral therapy 2007;12(8):1165-73.
2007: Marcel Wolbers; Manuel Battegay; Bernard Hirschel; Hansjakob Furrer; Matthias Cavassini; Barbara Hasse; Pietro L Vernazza; Enos Bernasconi; Gilbert R Kaufmann; Heiner C Bucher
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Antiviral therapy 2007;12(6):889-97.
2007: Dorothea M Wunder; Nick A Bersinger; Christoph A Fux; Nicolas Mueller; Bernard Hirschel; Matthias Cavassini; Luigia Elzi; Patrick Schmid; Enos Bernasconi; Bruno Mueller; Hansjakob Furrer
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.
Antiviral therapy 2007;12(2):261-5.
2007: Luigia Elzi; Matthias Schlegel; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Patrick Schmid; Enos Bernasconi; Martin Rickenbach; Hansjakob Furrer
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):94-102.
2006: Silvia Franceschi; Jerry Polesel; Martin Rickenbach; Luigino Dal Maso; Nicole M Probst-Hensch; C Fux; Matthias Cavassini; Barbara Hasse; Andreas Kofler; bruno ledergerber; Peter Erb; Gary M Clifford
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.
British journal of cancer 2006;95(11):1598-602.
2006: Sara Colombo; Thierry Buclin; Matthias Cavassini; Laurent A Décosterd; Amalio Telenti; Jérôme Biollaz; Chantal Csajka
Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 2006;50(11):3801-8.
2006: Tracy R Glass; Chaiwat Ungsedhapand; Marcel Wolbers; Rainer Weber; Pietro L Vernazza; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Matthias Cavassini; Bernard Hirschel; Manuel Battegay; Heiner C Bucher
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
HIV medicine 2006;7(6):404-10.
2006: Jintanat Ananworanich; Angèle Gayet-Ageron; Michelle Le Braz; Wisit Prasithsirikul; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Warangkana Munsakul; Phitsanu Raksakulkarn; Somboon Tansuphasawasdikul; Sunee Sirivichayakul; Matthias Cavassini; Urs Karrer; Daniel Genné; Reto Nüesch; Pietro Vernazza; Enos Bernasconi; Dominic Leduc; Claudette Satchell; Sabine Yerly; Luc Perrin; Andrew Hill; Thomas Perneger; Praphan Phanuphak; Hansjakob Furrer; David Cooper; Kiat Ruxrungtham; Bernard Hirschel
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial.
Lancet 2006;368(9534):459-65.
2006: S Bertschy; Milos Opravil; Matthias Cavassini; Enos Bernasconi; Veronique Schiffer; P Schmid; Markus Flepp; Jean-Philippe Chave; Anna Christen; Hansjakob Furrer
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(7):666-71.
2006: Jacques Fellay; Matthias Cavassini
[HIV-AIDS: answers to new questions].
Revue médicale suisse 2006;2(60):912-7.
2006: Nicolas J Müller; Hansjakob Furrer; Laurent Kaiser; Bernard Hirschel; Matthias Cavassini; Jacques Fellay; Jean-Philippe Chave; Rudolf P Wüthrich; Markus Weber; Beat Müllhaupt; Daniel Candinas; Jürg Reichen; Emiliano Giostra; Gilles Mentha; Nermin Halkic; Hans Hirsch; Rainer Weber
HIV and solid organ transplantation: the Swiss experience.
Swiss medical weekly 2006;136(11-12):194-6.
2006: Tracy R Glass; Sabina De Geest; Rainer Weber; Pietro L Vernazza; Martin Rickenbach; Hansjakob Furrer; Enos Bernasconi; Matthias Cavassini; Bernard Hirschel; Manuel Battegay; Heiner C Bucher
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.
Journal of acquired immune deficiency syndromes (1999) 2006;41(3):385-92.
2006: Sara Colombo; Thierry Buclin; Claudia Franc; Nicole Guignard; Mona Khonkarly; Philip E Tarr; Bertrand Rochat; Jérôme Biollaz; Amalio Telenti; Laurent A Decosterd; Matthias Cavassini
Ritonavir-boosted atazanavir-lopinavir combination: a pharmacokinetic interaction study of total, unbound plasma and cellular exposures.
Antiviral therapy 2006;11(1):53-62.
2005: Urs Karrer; bruno ledergerber; Hansjakob Furrer; Luigia Elzi; Manuel Battegay; Matthias Cavassini; Angèle Gayet-Ageron; Bernard Hirschel; Patrick Schmid; Marina Russotti; Rainer Weber; Roberto F Speck
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir.
AIDS (London, England) 2005;19(17):1987-94.
2005: Dorothea M Wunder; Nick A Bersinger; Christoph Fux; Rainer Weber; Enos Bernasconi; Matthias Cavassini; Heiner C Bucher; Veronique Schiffer; Patrick Schmid; Hansjakob Furrer
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy.
AIDS (London, England) 2005;19(16):1837-42.
2005: Gilbert R Kaufmann; Hansjakob Furrer; bruno ledergerber; Luc Perrin; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(3):361-72.
2005: Valérie D'Acremont; Matthias Cavassini; Philip E Tarr; Blaise Genton
[HIV and travel].
Revue médicale suisse 2005;1(19):1268-74.
2005: John Hornberger; Jesse Green; Neil Wintfeld; Matthias Cavassini; Jürgen Rockstroh; Giovanni Giuliani; Claudio De Carli; Adriano Lazzarin
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy.
HIV clinical trials 2005;6(2):92-102.
2005: Maura Prella; Jacques Bille; Mauro Pugnale; Bertrand Duvoisin; Matthias Cavassini; Thierry Calandra; Oscar Marchetti
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies.
Diagnostic microbiology and infectious disease 2005;51(2):95-101.
2005: Christian Mottet; A A El Wafa; Matthias Cavassini; V D'Acremont; Joakim Delarive
[Infectious diarrhea].
Revue médicale suisse 2005;1(3):209-10, 213-7.
2005: Y Fournier; C Bellini; Audrey Sylvia Baur; Gerard Waeber; Matthias Cavassini
[Disseminated cryptococcosis as inaugural manifestation of AIDS].
Praxis 2005;94(1-2):17-23.
2004: Claudine Zellweger; Milos Opravil; Enos Bernasconi; Matthias Cavassini; Heiner C Bucher; Veronique Schiffer; Thomas Wagels; Markus Flepp; Martin Rickenbach; Hansjakob Furrer
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.
AIDS (London, England) 2004;18(15):2047-53.
2004: Tracy R Glass; Jim Young; Pietro L Vernazza; Martin Rickenbach; Rainer Weber; Matthias Cavassini; Bernard Hirschel; Manuel Battegay; Heiner C Bucher
Is unsafe sexual behaviour increasing among HIV-infected individuals?
AIDS (London, England) 2004;18(12):1707-14.
2004: Sabine Yerly; Stéphanie Jost; Martine Monnat; Amalio Telenti; Matthias Cavassini; Jean-Philippe Chave; Laurent Kaiser; Philippe Burgisser; Luc Perrin
HIV-1 co/super-infection in intravenous drug users.
AIDS (London, England) 2004;18(10):1413-21.
2004: Christoph Strub; Gilbert R Kaufmann; Markus Flepp; Martin Egger; Christian Kahlert; Matthias Cavassini; Manuel Battegay
Gynecomastia and potent antiretroviral therapy.
AIDS (London, England) 2004;18(9):1347-9.
2004: Gilbert R Kaufmann; Nina Khanna; Rainer Weber; Luc Perrin; Hansjakob Furrer; Matthias Cavassini; bruno ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
Antiviral therapy 2004;9(2):263-74.
2004: Sophie Guyot; Daniel Hayoz; Amalio Telenti; Matthias Cavassini
Peripheral oedema and high arterial blood flow as a complication of antiretroviral therapy.
AIDS (London, England) 2004;18(2):356-8.
2003: Jintanat Ananworanich; Reto Nüesch; Michelle Le Braz; Ploenchan Chetchotisakd; Asda Vibhagool; Saijai Wicharuk; Kiat Ruxrungtham; Hansjakob Furrer; David Cooper; Bernard Hirschel; Enos Bernasconi; Matthias Cavassini; C Ebnöther; Catherine Fagard; Daniel Genné; N Khanna; Luc Perrin; Praphan Phanupak; Sasiwimol Ubolyam; Pietro Vernazza; Sabine Yerly
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial.
AIDS (London, England) 2003;17(15):F33-7.
2002: Matthias Cavassini; Mattia Lepori; Audrey Sylvia Baur; Jacques Bille; Marie-Denise Schaller; Oscar Marchetti
Disseminated histoplasmosis in Switzerland: an unexpected cause of septic shock and multiple organ dysfunction.
Intensive care medicine 2002;28(10):1501-2.
1999: Matthias Cavassini; Aline Wenger; Katia Jaton; Dominique Blanc; Jacques Bille
Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus.
Journal of clinical microbiology 1999;37(5):1591-4.